Keyphrases
Adalimumab
62%
Aliquot
12%
Alloimmune
12%
Alloimmune Disease
12%
Autoimmune
12%
Autoimmune Disease
12%
Cellular Uptake
12%
Ex Vivo Placental Perfusion
100%
Extravillous Trophoblast
37%
Fc Receptor
12%
FcRn
100%
Fetal Circulation
12%
Fetal Diseases
12%
Fetus
37%
Fully Human
12%
Healthy Volunteers
12%
High Affinity
12%
Human Immunoglobulin
12%
Human Placenta
12%
Immune-mediated Diseases
12%
Immunoglobulin G
100%
Immunoglobulin G Antibodies
25%
Immunoglobulin G1
25%
Meso Scale Discovery
12%
Monoclonal Antibody
12%
Monoclonal Immunoglobulin
12%
Neonatal Disease
12%
Neonatal Fc Receptor
75%
Neonate
12%
Non-inferiority Trial
12%
Novel Agents
12%
Pathophysiology
12%
Perfusion Model
100%
Phase 1 Study
12%
Placental Cells
12%
Placental Transfer
37%
Pregnancy Disorders
12%
Receptor Occupancy
12%
Sandwich Immunoassay
12%
Therapeutic Strategies
12%
Transfer Rate
25%
Immunology and Microbiology
Adalimumab
62%
Autoimmune Disease
12%
Enzyme-Linked Immunosorbent Assay
12%
Fc Receptor
12%
Fetus Circulation
12%
Human Immunoglobulin
12%
Immunity
12%
Immunoglobulin G
100%
Immunoglobulin G Antibody
25%
Immunoglobulin G1
25%
Immunology
100%
Monoclonal Antibody
12%
Neonatal Fc Receptor
75%
Normal Human
12%
Placenta
12%
Placenta Perfusion
100%
Placental Transfer
37%
Preclinical Study
12%
Receptor Antibody
12%
Receptor Occupancy
12%
Trophoblast
37%